MAR 16, 2016 7:10 AM PDT

STING Agonists Induce Apoptosis in Malignant B Cells

WRITTEN BY: Xuan Pham

Wistar Institute researchers recently discovered a protein in the endoplasmic reticulum of the cell, called STING, can induce death of malignant B-cells. Because malignant B-cells are the cause of several lymphomas, new drugs that stimulate the production of STING could offer better directed treatments for conditions like chronic lymphocytic leukemia and multiple myeloma.
 

Image credit: Pixabay.com

Located on the cell’s endoplasmic reticulum (ER), STING or Stimulator of Interferon Genes, is involved in producing type 1 interferons, which are immune mediators that help regulate the immune system. Drugs that stimulate responses mediated by STING, called STING agonists, are known to boost production of interferons and thus enhance the immune responses. As such, STING agonists have been used as adjuvant therapies to complement and augment primary cancer treatments.
 
Recently, researchers found that STING agonists didn’t just work by augmenting the response of the main cancer drug; rather, they found that STING agonists had the potential to induce programmed cell death in both normal and malignant B-cells.
 
"In non-B cells, STING agonists stimulate the production of interferons, but since they induce apoptosis in B cells, these B cells do not live long enough to help boost the immune response," said Chih-Chi Andrew Hu, associate professor at the Wistar Institute and senior study-author. "We wanted to determine why STING agonists behave differently in normal and malignant B cells and how to extend this cytotoxic activity in malignant B cell leukemia, lymphoma and multiple myeloma."
 
To that end, the researchers identified an essential stress response pathway associated with the ER: the IRE-1/XBP-1 pathway. Cells lacking the necessary components IRE-1 or XPB-1 can’t produce interferons from STING stimulation. More crucially, the survival of B-cell lymphomas is dependent this pathway, which researchers showed was conveniently suppressed by STING agonists. Thus, by understanding the related complexity of this pathway, the researchers may have found a new way to treat lymphomas, using STING agonists as the primary therapy.
 

 
The team confirmed their results in mouse models of chronic lymphocytic leukemia and multiple myeloma, where they observed consistent cancer regression with the application of STING agonists. This validated their hypothesis that stimulation of STING suppresses the IRE-1/XBP-1 pathway, which increased apoptosis in cancerous B-cells.
 
“This specific cytotoxicity toward B cells strongly supports the use of STING agonists in the treatment of B cell malignancies," said Chih-Hang Anthony Tang, first study author. "We also believe that cytotoxicity in normal B cells can be managed with the administration of intravenous immunoglobulin that can help maintain normal levels of antibodies while treatment is being administered. This is something we plan on studying further."

Additional source: Wistar Institute press release

About the Author
I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 28, 2022
Cell & Molecular Biology
From sample collection straight to RT-qPCR
NOV 28, 2022
From sample collection straight to RT-qPCR
Skip the nucleic acid purification step in your cancer detection workflow. Learn more about how Thermo Fisher Scientific ...
AUG 02, 2022
Cell & Molecular Biology
A New, Innovative Process for Clarifying and Sterile Filtering Cells for Protein Purification Workflows
AUG 02, 2022
A New, Innovative Process for Clarifying and Sterile Filtering Cells for Protein Purification Workflows
Introduction Centrifugation and filtration have been widely accepted as techniques required for clarifying complex cell ...
JUL 14, 2022
Cancer
Acupuncture Can Help Control Cancer-Related Pain
JUL 14, 2022
Acupuncture Can Help Control Cancer-Related Pain
Acupuncture is a traditional Chinese medicine (TCM) technique aiming to stimulate specific points in the body.  In ...
AUG 21, 2022
Cancer
The Legacy of Lady Mary Wortley Montagu
AUG 21, 2022
The Legacy of Lady Mary Wortley Montagu
Today, August 21, marks the 260th anniversary of the passing of a pioneer in the medical field.  In 1762, Lady Mary ...
NOV 11, 2022
Cancer
Veterans and Burn Pit Exposure
NOV 11, 2022
Veterans and Burn Pit Exposure
Today we recognize the Veterans Day holiday in the United States.  Each year, on November 11, Americans commemorate ...
NOV 29, 2022
Drug Discovery & Development
Chemotherapy May Increase Disease Susceptibility for Two Generations
NOV 29, 2022
Chemotherapy May Increase Disease Susceptibility for Two Generations
A common chemotherapy drug may make future generations more susceptible to disease. The corresponding study was publishe ...
Loading Comments...